These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32099511)

  • 1. Erratum: Depot Buprenorphine Injection in the Management of Opioid Use Disorder: From Development to Implementation [Corrigendum].
    Subst Abuse Rehabil; 2020; 11():19-20. PubMed ID: 32099511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid users' willingness to receive prolonged-release buprenorphine depot injections for opioid use disorder.
    Tompkins CNE; Neale J; Strang J
    J Subst Abuse Treat; 2019 Sep; 104():64-71. PubMed ID: 31370986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification.
    Sobel BF; Sigmon SC; Walsh SL; Johnson RE; Liebson IA; Nuwayser ES; Kerrigan JH; Bigelow GE
    Drug Alcohol Depend; 2004 Jan; 73(1):11-22. PubMed ID: 14687955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an injection depot formulation of buprenorphine: placebo comparison.
    Sigmon SC; Wong CJ; Chausmer AL; Liebson IA; Bigelow GE
    Addiction; 2004 Nov; 99(11):1439-49. PubMed ID: 15500597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation.
    Ling W; Shoptaw S; Goodman-Meza D
    Subst Abuse Rehabil; 2019; 10():69-78. PubMed ID: 31819701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An injection depot formulation of buprenorphine: extended bio-delivery and effects.
    Sigmon SC; Moody DE; Nuwayser ES; Bigelow GE
    Addiction; 2006 Mar; 101(3):420-32. PubMed ID: 16499515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of buprenorphine depot injection for opioid use disorder.
    Allikmets S; Vink JP
    Addiction; 2020 Jan; 115(1):190. PubMed ID: 31521065
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Haight BR; Learned SM; Laffont CM; Fudala PJ; Zhao Y; Garofalo AS; Greenwald MK; Nadipelli VR; Ling W; Heidbreder C;
    Lancet; 2019 Feb; 393(10173):778-790. PubMed ID: 30792007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences.
    Neale J; Tompkins CNE; Strang J
    Drug Alcohol Rev; 2019 Jul; 38(5):510-518. PubMed ID: 31131514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of a buprenorphine subcutaneous depot formulation (CAM2038) for once-weekly dosing in patients with opioid use disorder.
    Haasen C; Linden M; Tiberg F
    J Subst Abuse Treat; 2017 Jul; 78():22-29. PubMed ID: 28554599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial.
    Walsh SL; Comer SD; Lofwall MR; Vince B; Levy-Cooperman N; Kelsh D; Coe MA; Jones JD; Nuzzo PA; Tiberg F; Sheldon B; Kim S
    JAMA Psychiatry; 2017 Sep; 74(9):894-902. PubMed ID: 28655025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Triglyceride-mimetic prodrugs of buprenorphine enhance oral bioavailability via promotion of lymphatic transport.
    Quach T; Hu L; Han S; Lim SF; Senyschyn D; Yadav P; Trevaskis NL; Simpson JS; Porter CJH
    Front Pharmacol; 2022; 13():1014363. PubMed ID: 36133812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New slow-release buprenorphine formulations for optimization of opioid substitution].
    Soyka M; Pogarell O
    Nervenarzt; 2019 Sep; 90(9):932-937. PubMed ID: 31399813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Mental health in UK Biobank: development, implementation and results from an online questionnaire completed by 157 366 participants - CORRIGENDUM.
    Davis KAS; Coleman JRI; Adams M; Allen N; Breen G; Cullen B; Dickens C; Fox E; Graham N; Holliday J; Howard LM; John A; Lee W; McCabe R; McIntosh A; Pearsall R; Smith DJ; Sudlow C; Ward J; Zammit S; Hotopf M
    BJPsych Open; 2018 Sep; 4(5):352-353. PubMed ID: 30140447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum.
    Sci Technol Adv Mater; 2016; 17(1):188. PubMed ID: 27889790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Increased radiosensitivity of colorectal tumors with intra-tumoral injection of low dose of gold nanoparticles [Corrigendum].
    Int J Nanomedicine; 2019; 14():mmmmmmmcccvii. PubMed ID: 31571875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine.
    Vorspan F; Hjelmström P; Simon N; Benyamina A; Dervaux A; Brousse G; Jamain T; Kosim M; Rolland B
    Expert Opin Drug Deliv; 2019 Sep; 16(9):907-914. PubMed ID: 31364884
    [No Abstract]   [Full Text] [Related]  

  • 18. Erratum to:
    Pilot and Feasibility Studies
    Pilot Feasibility Stud; 2017; 3():48. PubMed ID: 29123916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Mental health in UK Biobank: development, implementation and results from an online questionnaire completed by 157 366 participants - CORRIGENDUM.
    Davis KAS; Coleman JRI; Adams M; Allen N; Breen G; Cullen B; Dickens C; Fox E; Graham N; Holliday J; Howard LM; John A; Lee W; McCabe R; McIntosh A; Pearsall R; Sudlow C; Ward J; Zammit S; Hotopf M
    BJPsych Open; 2018 May; 4(3):136. PubMed ID: 29974892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
    Harrison TK; Kornfeld H; Aggarwal AK; Lembke A
    Anesthesiol Clin; 2018 Sep; 36(3):345-359. PubMed ID: 30092933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.